New Formulation Doubles Vaccine Shelf Life Without Refrigeration
Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
Season’s First Snowfall Covers Upper Himalayan Valleys 
UPI Expansion to Global Markets 
Next Gen Gaming Consoles Unveiled with India Specific Features, Real Time Cloud Play 
Red Bull sacks Horner